These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21228703)

  • 1. Common polymorphisms in the microsomal epoxide hydrolase and N-acetyltransferase 2 genes in association with inflammatory bowel disease in the Danish population.
    Ernst A; Andersen V; Ostergaard M; Jacobsen BA; Pedersen IS; Drewes AM; Okkels H; Krarup HB
    Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):269-74. PubMed ID: 21228703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk.
    Brockmöller J; Cascorbi I; Kerb R; Roots I
    Cancer Res; 1996 Sep; 56(17):3915-25. PubMed ID: 8752158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer.
    Zhou W; Liu G; Thurston SW; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):15-21. PubMed ID: 11815396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
    Karlsen TH; Hampe J; Wiencke K; Schrumpf E; Thorsby E; Lie BA; Broomé U; Schreiber S; Boberg KM
    Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of polymorphisms of tumor necrosis factor-alpha and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: study from northern India.
    Mittal RD; Manchanda PK; Bid HK; Ghoshal UC
    J Gastroenterol Hepatol; 2007 Jun; 22(6):920-4. PubMed ID: 17565649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
    Srivastava DS; Mandhani A; Mittal RD
    Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.
    Sonzogni L; Silvestri L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Bottelli R; Mondelli MU; Civardi E; Silini EM
    Hepatology; 2002 Jul; 36(1):195-201. PubMed ID: 12085365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of thiopurine therapy in paediatric IBD patients.
    De Ridder L; Van Dieren JM; Van Deventer HJ; Stokkers PC; Van der Woude JC; Van Vuuren AJ; Benninga MA; Escher JC; Hommes DW
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1137-41. PubMed ID: 16611274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on the epidemiology of inflammatory bowel disease in Asia.
    Thia KT; Loftus EV; Sandborn WJ; Yang SK
    Am J Gastroenterol; 2008 Dec; 103(12):3167-82. PubMed ID: 19086963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intercellular adhesion molecule 1 gene polymorphisms in inflammatory bowel disease.
    Papa A; Danese S; Urgesi R; Grillo A; Guglielmo S; Roberto I; Semeraro S; Scaldaferri F; Pola R; Flex A; Fedeli G; Gasbarrini G; Pola P; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2004; 8(5):187-91. PubMed ID: 15638228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
    Cao Q; Zhu Q; Shang Y; Gao M; Si J
    Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab for inflammatory bowel disease in Denmark 1999-2005: clinical outcome and follow-up evaluation of malignancy and mortality.
    Caspersen S; Elkjaer M; Riis L; Pedersen N; Mortensen C; Jess T; Sarto P; Hansen TS; Wewer V; Bendtsen F; Moesgaard F; Munkholm P;
    Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1212-7; quiz 1176. PubMed ID: 18848503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsomal epoxide hydrolase polymorphism and risk of spontaneous abortion.
    Wang X; Wang M; Niu T; Chen C; Xu X
    Epidemiology; 1998 Sep; 9(5):540-4. PubMed ID: 9730034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease.
    McGovern DP; Hysi P; Ahmad T; van Heel DA; Moffatt MF; Carey A; Cookson WO; Jewell DP
    Hum Mol Genet; 2005 May; 14(10):1245-50. PubMed ID: 15790594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of SLC11A1 as an inflammatory bowel disease candidate gene.
    Crawford NP; Eichenberger MR; Colliver DW; Lewis RK; Cobbs GA; Petras RE; Galandiuk S
    BMC Med Genet; 2005 Mar; 6():10. PubMed ID: 15757519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication of an association between IL23R gene polymorphism with inflammatory bowel disease.
    Oliver J; Rueda B; López-Nevot MA; Gómez-García M; Martín J
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):977-81, 981.e1-2. PubMed ID: 17678845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms.
    Balding J; Livingstone WJ; Conroy J; Mynett-Johnson L; Weir DG; Mahmud N; Smith OP
    Mediators Inflamm; 2004 Jun; 13(3):181-7. PubMed ID: 15223609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease.
    Celik Y; Dagli U; Kiliç MY; Törüner M; Ozen SC; Ozkan M; Soykan I; Cetinkaya H; Ulker A; Ozden A; Bozdayi AM
    Scand J Gastroenterol; 2006 May; 41(5):559-65. PubMed ID: 16638698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel pharmacogenetic markers for treatment outcome in azathioprine-treated inflammatory bowel disease.
    Smith MA; Marinaki AM; Arenas M; Shobowale-Bakre M; Lewis CM; Ansari A; Duley J; Sanderson JD
    Aliment Pharmacol Ther; 2009 Aug; 30(4):375-84. PubMed ID: 19500084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of genetic polymorphism of glutathione-S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma.
    Tiemersma EW; Omer RE; Bunschoten A; van't Veer P; Kok FJ; Idris MO; Kadaru AM; Fedail SS; Kampman E
    Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):785-91. PubMed ID: 11440964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.